Eckhart G. Hahn
University of Erlangen-Nuremberg
508 Papers
7.1K Citations
Eckhart G. Hahn is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Gastric mucosa & Medicine. The author has an hindex of 71, co-authored 507 publications.
Chat about Author
Papers
Readmissions and adverse drug reactions in internal medicine: the economic impact.
Harald Dormann,Antje Neubert,Manfred Criegee-Rieck,Tobias Egger,Martin Radespiel-Tröger,Tanya Azaz-Livshits,Micha Levy,Kay Brune,Eckhart G. Hahn +8 more
TL;DR: This study focuses on the relationship between adverse drug reactions (ADRs) and readmittance to a department of internal medicine and the number of patients readmitted to hospital within 6 months of discharge.
138
Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease.
TL;DR: Clear evidence is provided from viable endoscopic colorectal samples that mast cell mediators were secreted during active inflammation in CD and UC, however, the extent of mast cell involvement and activation differs considerably between CD andUC.
136
The role of melatonin and L‐tryptophan in prevention of acute gastric lesions induced by stress, ethanol, ischemia, and aspirin
Tomasz Brzozowski,P C Konturek,Stanislaw J. Konturek,Robert Pajdo,Wladyslaw Bielanski,Iwona Brzozowska,Jerzy Stachura,Eckhart G. Hahn +7 more
TL;DR: The role of melatonin and L‐tryptophan in prevention of acute gastric lesions induced by stress, ethanol, ischemia, and aspirin is studied.
135
Pancreatic duct stones in chronic pancreatitis: criteria for treatment intensity and success.
MJ Farnbacher,Christoph Schoen,Thomas Rabenstein,J. Benninger,Eckhart G. Hahn,H. Thomas Schneider +5 more
TL;DR: In this article, the authors evaluated interventional endoscopic management of pancreatic duct stones in patients with chronic pancreatitis by describing therapeutic methods and defining factors that predict technical success, including patient age and prepapillary location of stones.
134
Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases.
J. Hänsler,Thaddäus Till Wissniowski,Detlef Schuppan,Astrid Witte,Thomas Bernatik,Eckhart G. Hahn,Deike Strobel +6 more
TL;DR: Patients with primary and secondary tumors of the liver show a significant tumor-specific cytotoxic T-cell stimulation with a dramatically increased tumor specific cytolytic activity of CD8(+) T cells after RFA.
133